In order to test myotube atrophy from a second mouse tumor that is known for making high levels of LIF (Tomida et al., 1984), Ehrlich ascites carcinoma cells were used in the same two treatment designs as C26 to treat C2C12 myotubes. Here, LIF is linked to neoplasm.